IL6 and type 2 diabetes mellitus: These phenomena are accompanied by abnormal release of FA, adipokines, and proinflammatory molecules including TNFα, interleukin (IL)-6, and IL-1β which, by acting on target organs, induce insulin resistance and favor the onset of type 2 diabetes (21, 46).